AETHLON MEDICAL INC (AEMD) › Shares OutstandingAETHLON MEDICAL INC (AEMD) — Shares OutstandingAnnual figures by period end, from SEC filings.2011-03-31: 77.47M2012-03-31: 117.52M2013-03-31: 173.67M2014-03-31: 4.50M2015-03-31: 6.66M2016-03-31: 7.62M2017-03-31: 8.80M2018-03-31: 17.74M2019-03-31: 1.27M2020-03-31: 9.37M2021-03-31: 12.15M2022-03-31: 15.42M2023-03-31: 2.30M2024-03-31: 328.7K2025-03-31: 201.1K2026-03-31: 1.57M1.57M2011-03-31Shares Outstanding (shares)2026-03-31Period endedShares OutstandingChange YoYSource filing2026-03-311.57M+681.0%2026-06-10Balance as of period end2025-03-31201.1K-38.8%2026-06-10Balance as of period end2024-03-31328.7K-85.7%2025-06-26Balance as of period end2023-03-312.30M-85.1%2024-06-27Balance as of period end2022-03-3115.42M+26.9%2023-06-28Balance as of period end2021-03-3112.15M+29.7%2022-06-28Balance as of period end2020-03-319.37M+639.3%2021-06-24Balance as of period end2019-03-311.27M-92.9%2020-06-25Balance as of period end2018-03-3117.74M+101.7%2019-07-01Balance as of period end2017-03-318.80M+15.4%2018-06-08Balance as of period end2016-03-317.62M+14.5%2017-06-28Balance as of period end2015-03-316.66M+48.0%2016-06-29Balance as of period end2014-03-314.50M-97.4%2015-07-13Balance as of period end2013-03-31173.67M+47.8%2014-07-15Balance as of period end2012-03-31117.52M+51.7%2013-07-15Balance as of period end2011-03-3177.47M—2012-06-29Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per ShareWeighted Average Diluted SharesEPS (Basic)